المنتجات الصيدلية
Shaping the Future of Pharmaceutical Manufacturing with Smart Solutions.
قراءة المزيد
Unlock the future of pharmaceutical manufacturing with GEA Pharma & Healthcare, where innovation meets sustainability, operational excellence and security of supply. In a dynamic market, GEA is your strategic partner, offering cutting-edge solutions that redefine the balance between performance and environmental responsibility.
Successfully bringing a pharmaceutical product to market can be a challenging journey. As innovators and operators, we understand the importance of mapping out and optimizing your projects with precision. That’s why we are here to offer you guidance and support every step of the way.
Markets
Our portfolio includes single units, modular systems and complete production lines for powder processing, oral solid dosage forms, parenterals, liquids, semi-solids and nutraceuticals. So, wherever you are, whatever the scale of your operation or indication, we have the capability to make your concept a reality, optimize your process, improve your production efficiency and deliver the ongoing support to make your business a success.
At the heart of our commitment is the fusion of compliance, cost-efficiency and quality. GEA technology is reliable, flexible and economical. What’s more, we go beyond equipment by offering comprehensive training programs that empower your staff.
Sustainability by Design
In the ever-evolving landscape of pharmaceuticals, GEA understands the importance of sustainability, return on investment and optimal resource utilization. With facilities worldwide adhering to precise standards, we offer a vast variety of process
Test before you invest.
Committed to advancing our customers’ research and development activities, GEA’s pharmaceutical technology test centers provide global technical support and know-how to the pharmaceutical industry.
These centers of excellence give you access to a full range of test facilities and teams of experts, all of whom work closely with our customers to optimize processes and evaluate their products, enabling them to achieve their process and production goals in a cost-effective way.
Pharma & healthcare Insight Stories
Continuous Innovation: How GEA is Leading the Future of Pharmaceutical Manufacturing
From the first ConsiGma® line in 2004 to the launch of CDC Flex today, GEA has been at the forefront of pharmaceutical innovation.
Continuous innovation is our commitment — to our customers, to the industry, and to a better world.
.jpg?h=1350&iar=0&w=2400&rev=1b429cc0c71d46d499711e0731d4a0cd&hash=BB51B496350FA3FA7A4E892151983C5E&mw=3840 "biopharma industry")
تعمل فاصلات التروية على تسريع عمليات المعالجة الخاصة بمنتجات الصيدلة الحيوية
غالبًا ما تكون الشركات المصنعة لمنتجات الصيدلة الحيوية الصغيرة هي القوة الدافعة وراء انتشار العلاجات الطبية المبتكرة. وتعمل GEA على إحداث ثورة في قدرات حصاد الخلايا لهذه الشركات المصنعة من خلال استخدام فاصلات التروية التي تتيح المعالجة المستمرة محسنة الكفاءة. ولأول مرة، تم تحويل فاصلات الأقراص المكدسة المناسبة إلى آلات مدمجة أحادية الاستخدام، مما يوفر المساحة والعمالة والجهد، مع تمهيد الطريق لزيادة قدرة الإنتاج وسرعته.
المنتجات والتقنيات
يتم عرض 4 من 46
Contained Materials Handling Systems
Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.
Continuous Direct Compression Line
The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.
Continuous Granulation Lines
Continuous Processing is becoming more and more important in the pharmaceutical industry. GEA takes the lead in introducing this innovative technology with ConsiGma® - continuous high-shear granulation and drying lines.
Continuous Processing Lines for Pharma
At GEA, we believe that continuous processing improves the quality of pharmaceutical end products: by focusing on quality during the whole product lifecycle, not just “tested in” quality; and by understanding the capability of your processes, managing sources of variability and decreasing any associated risks.
